Case Report
BibTex RIS Cite

A Rare Cause of Chylothorax in Children: Gorham-Stout Syndrome

Year 2019, Volume: 13 Issue: 1, 36 - 39, 21.03.2019
https://doi.org/10.12956/tjpd.2018.375

Abstract







 Gorham-Stout disease is a complex disease in which lytic lesions of bone tissue are accompanied by chylothorax and abdominal lymphangioma. The etiology is still unknown. The diagnosis is made by the patient’s clinical and laboratory findings and biopsy results. It may be fatal depending on the organs involved. Although many treatments have been described, successful results have been reported with interferon alpha 2b in recent years. We discuss the clinical diagnosis and treatment of a 5-year-old female patient with osteolytic lesions in the bones after she was referred with chylothorax 

References

  • 1. Noda M, Endo C, Hoshikawa Y, et al. Successful management of intractable chylothorax in Gorham-Stout disease by awake thoracoscopic surgery. Gen Thorac Cardiovasc Surg. 2013;61(6):356- 8.
  • 2. De Smet K, De Maeseneer M, Huijssen-Huisman E, Van Gorp V, Hachimi-Idrissi S, Ernst C. A rare cause of dyspnea due to chylothorax. Emerg Radiol 2010;17:503-5.
  • 3. Kuriyama DK, McElligott SC, Glaser DW, Thompson KS. Treatment of Gorham-Stout disease with zoledronic acid and interferon-α: A case report and literature review. J Pediatr Hematol Oncol 2010;32:579-584.
  • 4. Brodszki N, Länsberg J-K, Dictor M, et al. A novel treatment approach for paediatric Gorham–Stout syndrome with chylothorax. Acta Paediatr 2011;100:1448-53.
  • 5. Deveci M, Inan N, Çorapçioǧlu F, Ekingen G. Gorham-Stout syndrome with chylothorax in a six-year-old boy. Indian J Pediatr. 2011;78:737-9.
  • 6. Brodszki N, Länsberg JK, Dictor M, et al. A novel treatment approach for paediatric Gorham-Stout syndrome with chylothorax. Acta Paediatr Int J Paediatr 2011;100:1448-53.
  • 7. Nozawa A, Ozeki M, Kuze B, Asano T, Matsuoka K, Fukao T. Gorham-Stout disease of the skull base with hearing loss: Dramatic recovery and antiangiogenic therapy. Pediatr Blood Cancer 2016;63:931-4.
  • 8. Gorham Lw, Stout AP. Massive osteolysis (acute spontaneous absorption of bone, phantom bone, disappearing bone); its relation to hemangiomatosis. J Bone Joint Surg Am 1955;37-A(5):985- 1004.
  • 9. Patel DV. Gorham’s disease or massive osteolysis. Clin Med Res 2005;3:65-74.
  • 10. Kakhaki AD, Khodadad K, Pejhan S, Karimi S, Arab M, Saghebi R, et al. Gorham’s Disease with chest wall involvement: A case report and a review of the literature. Iran Red Crescent Med J 2014;16. e12180.
  • 11. Kose M, Pekcan S, Dogru D, Akyuz C, Ozcelik U, Ozsurekci Y, et al. Gorham-Stout syndrome with chylothorax: Successful remission by interferon alpha-2b. Pediatr Pulmonol 2009;44:613-5.
  • 12. Trenor CC, Chaudry G. Complex lymphatic anomalies. Semin Pediatr Surg 2014;23:186-90.
  • 13. Ezekowitz RAB, Mulliken JB, Folkman J. Interferon Alfa-2a therapy for life-threatening hemangiomas of infancy. N Engl J Med 1992;326:1456-63.
  • 14. Takahashi A, Ogawa C, Kanazawa T, Watanabe H, Suzuki M, Suzuki N, et al. Remission induced by interferon alfa in a patient with massive osteolysis and extension of lymph-hemangiomatosis: A severe case of Gorham-Stout syndrome. J Pediatr Surg 2005;40:E47-E50.
  • 15. Timke C, Krause MF, Oppermann H, Leuschner I, Claviez A. Interferon alpha 2b treatment in an eleven-year-old boy with disseminated lymphangiomatosis. Pediatr Blood Cancer 2007;48:108-11.
  • 16. Hagberg H, Lamberg K, Aström G. Alpha-2b interferon and oral clodronate for Gorham’s disease. Lancet 1997;350:1822-3.
  • 17. Grunewald TGP, Damke L, Maschan M, Petrova U, Surianinova O, Esipenko A, et al. First report of effective and feasible treatment of multifocal lymphangiomatosis (Gorham-Stout) with bevacizumab in a child. Ann Oncol 2010;21:1733-4.

Çocuklarda Nadir Bir Şilotoraks Nedeni: Gorham-Stout Sendromu

Year 2019, Volume: 13 Issue: 1, 36 - 39, 21.03.2019
https://doi.org/10.12956/tjpd.2018.375

Abstract



 Gorham-stout hastalığı kemik dokusunun litik lezyonları ile birlikte şilotoraks ve abdominal lenfangiomanın olabildiği kompleks bir hastalıktır. Etiyolojisi halen bilinmemektedir. Tanısı hastanın kliniği, laboratuvar bulguları ve biyopsi ile konulur. Tutulan organlara göre ölümcül seyredebilir. Birçok tedavi tariflenmiş olmakla birlikte son yıllarda interferon alfa 2b ile başarılı sonuçlar bildirilmiştir. Biz burada şilotoraks ile başvuran, kemikte litik lezyonları olan 5 yaşındaki kız hastanın klinik tanısı ve tedavisini tartıştık. 

References

  • 1. Noda M, Endo C, Hoshikawa Y, et al. Successful management of intractable chylothorax in Gorham-Stout disease by awake thoracoscopic surgery. Gen Thorac Cardiovasc Surg. 2013;61(6):356- 8.
  • 2. De Smet K, De Maeseneer M, Huijssen-Huisman E, Van Gorp V, Hachimi-Idrissi S, Ernst C. A rare cause of dyspnea due to chylothorax. Emerg Radiol 2010;17:503-5.
  • 3. Kuriyama DK, McElligott SC, Glaser DW, Thompson KS. Treatment of Gorham-Stout disease with zoledronic acid and interferon-α: A case report and literature review. J Pediatr Hematol Oncol 2010;32:579-584.
  • 4. Brodszki N, Länsberg J-K, Dictor M, et al. A novel treatment approach for paediatric Gorham–Stout syndrome with chylothorax. Acta Paediatr 2011;100:1448-53.
  • 5. Deveci M, Inan N, Çorapçioǧlu F, Ekingen G. Gorham-Stout syndrome with chylothorax in a six-year-old boy. Indian J Pediatr. 2011;78:737-9.
  • 6. Brodszki N, Länsberg JK, Dictor M, et al. A novel treatment approach for paediatric Gorham-Stout syndrome with chylothorax. Acta Paediatr Int J Paediatr 2011;100:1448-53.
  • 7. Nozawa A, Ozeki M, Kuze B, Asano T, Matsuoka K, Fukao T. Gorham-Stout disease of the skull base with hearing loss: Dramatic recovery and antiangiogenic therapy. Pediatr Blood Cancer 2016;63:931-4.
  • 8. Gorham Lw, Stout AP. Massive osteolysis (acute spontaneous absorption of bone, phantom bone, disappearing bone); its relation to hemangiomatosis. J Bone Joint Surg Am 1955;37-A(5):985- 1004.
  • 9. Patel DV. Gorham’s disease or massive osteolysis. Clin Med Res 2005;3:65-74.
  • 10. Kakhaki AD, Khodadad K, Pejhan S, Karimi S, Arab M, Saghebi R, et al. Gorham’s Disease with chest wall involvement: A case report and a review of the literature. Iran Red Crescent Med J 2014;16. e12180.
  • 11. Kose M, Pekcan S, Dogru D, Akyuz C, Ozcelik U, Ozsurekci Y, et al. Gorham-Stout syndrome with chylothorax: Successful remission by interferon alpha-2b. Pediatr Pulmonol 2009;44:613-5.
  • 12. Trenor CC, Chaudry G. Complex lymphatic anomalies. Semin Pediatr Surg 2014;23:186-90.
  • 13. Ezekowitz RAB, Mulliken JB, Folkman J. Interferon Alfa-2a therapy for life-threatening hemangiomas of infancy. N Engl J Med 1992;326:1456-63.
  • 14. Takahashi A, Ogawa C, Kanazawa T, Watanabe H, Suzuki M, Suzuki N, et al. Remission induced by interferon alfa in a patient with massive osteolysis and extension of lymph-hemangiomatosis: A severe case of Gorham-Stout syndrome. J Pediatr Surg 2005;40:E47-E50.
  • 15. Timke C, Krause MF, Oppermann H, Leuschner I, Claviez A. Interferon alpha 2b treatment in an eleven-year-old boy with disseminated lymphangiomatosis. Pediatr Blood Cancer 2007;48:108-11.
  • 16. Hagberg H, Lamberg K, Aström G. Alpha-2b interferon and oral clodronate for Gorham’s disease. Lancet 1997;350:1822-3.
  • 17. Grunewald TGP, Damke L, Maschan M, Petrova U, Surianinova O, Esipenko A, et al. First report of effective and feasible treatment of multifocal lymphangiomatosis (Gorham-Stout) with bevacizumab in a child. Ann Oncol 2010;21:1733-4.
There are 17 citations in total.

Details

Primary Language Turkish
Subjects ​Internal Diseases
Journal Section CASE REPORTS
Authors

Engin Aydın

Publication Date March 21, 2019
Submission Date March 16, 2018
Published in Issue Year 2019 Volume: 13 Issue: 1

Cite

Vancouver Aydın E. Çocuklarda Nadir Bir Şilotoraks Nedeni: Gorham-Stout Sendromu. Türkiye Çocuk Hast Derg. 2019;13(1):36-9.


The publication language of Turkish Journal of Pediatric Disease is English.


Manuscripts submitted to the Turkish Journal of Pediatric Disease will go through a double-blind peer-review process. Each submission will be reviewed by at least two external, independent peer reviewers who are experts in the field, in order to ensure an unbiased evaluation process. The editorial board will invite an external and independent editor to manage the evaluation processes of manuscripts submitted by editors or by the editorial board members of the journal. The Editor in Chief is the final authority in the decision-making process for all submissions. Articles accepted for publication in the Turkish Journal of Pediatrics are put in the order of publication, with at least 10 original articles in each issue, taking into account the acceptance dates. If the articles sent to the reviewers for evaluation are assessed as a senior for publication by the reviewers, the section editor and the editor considering all aspects (originality, high scientific quality and citation potential), it receives publication priority in addition to the articles assigned for the next issue.


The aim of the Turkish Journal of Pediatrics is to publish high-quality original research articles that will contribute to the international literature in the field of general pediatric health and diseases and its sub-branches. It also publishes editorial opinions, letters to the editor, reviews, case reports, book reviews, comments on previously published articles, meeting and conference proceedings, announcements, and biography. In addition to the field of child health and diseases, the journal also includes articles prepared in fields such as surgery, dentistry, public health, nutrition and dietetics, social services, human genetics, basic sciences, psychology, psychiatry, educational sciences, sociology and nursing, provided that they are related to this field. can be published.